Literature DB >> 10755681

Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder.

T E Smith1, J W Hull, L M Israel, D F Willson.   

Abstract

There are conflicting reports in the literature regarding the relationships among impaired insight, symptoms, and neurocognition in schizophrenia. The inconsistent findings likely reflect the multidimensionality of insight in this population, along with variations in study design. We examined 46 individuals with chronic schizophrenia or schizoaffective disorder who were recently discharged from an inpatient unit. Insight was operationalized as awareness of having a mental disorder and awareness and attribution of both current and past symptoms. Positive, negative, disorganized, and depression symptoms were rated, and a neurocognition battery, including measures of visual processing, memory, visuo-spatial ability, and executive functions, was administered. Poor awareness of symptoms was moderately associated with core schizophrenia symptoms, and higher levels of depression were strongly associated with good awareness. Symptom misattribution, more so than symptom unawareness, was associated with deficits in frontal lobe functioning. Finally, different patterns of associations between symptoms, neurocognition, and insight were noted for current symptoms versus past symptoms. The data suggest that insight deficits in schizophrenia are multidimensional, and that investigators should pay careful attention to the choice of measures as well as to phase of illness characteristics in future studies.

Entities:  

Mesh:

Year:  2000        PMID: 10755681     DOI: 10.1093/oxfordjournals.schbul.a033439

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  23 in total

1.  Premorbid personality and insight in first-episode psychosis.

Authors:  Maria S Campos; Elena Garcia-Jalon; James K Gilleen; Anthony S David; Victor M D Peralta; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2010-10-25       Impact factor: 9.306

2.  Insight and regional brain volumes in schizophrenia.

Authors:  Débora Pastore Bassitt; Mario Rodrigues Louzä Neto; Cláudio Campi de Castro; Geraldo F Busatto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-02       Impact factor: 5.270

3.  Effects of theta-rhythm transcranial alternating current stimulation (4.5 Hz-tACS) in patients with clozapine-resistant negative symptoms of schizophrenia: a case series.

Authors:  Lassaad Kallel; Marine Mondino; Jerome Brunelin
Journal:  J Neural Transm (Vienna)       Date:  2016-05-19       Impact factor: 3.575

4.  Lack of motivation for treatment in emergency psychiatry patients.

Authors:  Cornelis L Mulder; Gerrit T Koopmans; Michiel W Hengeveld
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-06       Impact factor: 4.328

Review 5.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

6.  Theory of mind and unawareness of illness in schizophrenia: is poor insight a mentalizing deficit?

Authors:  Emre Bora; Gulsah Sehitoglu; Mustafa Aslier; Ihsan Atabay; Baybars Veznedaroglu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-14       Impact factor: 5.270

7.  The Beck Cognitive Insight Scale (BCIS): translation and validation of the Taiwanese version.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  BMC Psychiatry       Date:  2010-04-09       Impact factor: 3.630

Review 8.  Disorders of awareness in neuropsychiatric syndromes: an update.

Authors:  Laura A Flashman
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

9.  Insight in bipolar disorder: relationship to episode subtypes and symptom dimensions.

Authors:  Frederick Cassidy
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-05       Impact factor: 2.570

10.  Insight, cognitive dysfunction and symptomatology in schizophrenia.

Authors:  Luciana C Monteiro; Vanessa A Silva; Mario R Louzã
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.